SBRT Boost for Unfavorable Prostate Cancer'
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorMemorialCare Health System
About this trial
The purpose of this study is to find out whether giving a short course of focused radiation called an SBRT "boost" is a safe and effective way to treat prostate cancer. This boost delivers a high dose of radiation to the prostate in a non-invasive way, similar to what is done with high dose rate (HDR) brachytherapy but without using needles. The study looks at how well this treatment controls the cancer, what side effects it may cause, and how it affects patients' quality of life over time.
Eligibility criteria
Qualifiers
Histologically proven prostate adenocarcinoma
Biopsy within 12 months of date of registration required except for patients who already meet criteria for enrollment in the high risk arm of the protocol. For these patients, repeat biopsy will be at the discretion of the treating physician. In general, repeat biopsy is recommended for these patients, but is not required if it will not affect the treating physician's management decisions in regards to the care of the patient.
Clinical Stage I-IV, MX-M0 (AJCC VERSION 9)
M-stage determined by physical exam, CT, MRI, bone scan, PSMA PET/CT, or biopsy.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Stereotactic body radiotherapy (SBRT) Boost
Treatment groups
150 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov